Company / Operating Cash Flow
Immunocore Holdings plc Operating Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$10.7M
FY2025
5-year range
-$143.1M / $26.1M
FY2021-FY2025
Trend
-141.1%
vs FY2024
Sector context
#80 of 216
Health Care
What the data says
At -$11M, Immunocore Holdings plc's operating cash flow ranks #80 of 216 in the Health Care sector. Declined from $3M to -$11M over the past 2 years.
Based on SEC 10-K filings.
-$11M in FY2025.
Declined from $3M to -$11M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#80 of 216 in Health CareTop 37% of 216This company -$10.7M Sector average $658.7M
▼
-101.6% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 141.1% year-over-year.
- Ranks #80 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2024.
- Lowest operating cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$10.7M | -141.1% |
| FY2024 | $26.1M | +786.4% |
| FY2023 | $2.9M | +106.0% |
| FY2022 | -$49.2M | +65.6% |
| FY2021 | -$143.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026